Company Profiles

Find premium company profile research reports. Purchase and download high quality report analysis, company reports, and much more

DocStore Search:
Per Page: 152550
  • Infogroup, Inc. - Strategic SWOT Analysis Review
    Infogroup, Inc. - Strategic SWOT Analysis Review

    $125.00

    $125.00

    From:GlobalData

    Document Overview:
    Infogroup, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – GlobalData’s summarization of the company’s business strategy. - SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details. Highlights Infogroup Inc. (Infogroup) is a leading provider of innovative business data, and marketing solutions. Its clients include local businesses to the Fortune 100 companies. Its services are useful in finding new customers, augmenting the business, direct marketing, telemarketing, customer profiling and credit reference purposes. The key services offered by the company include sales solutions, marketing data solutions, email marketing, cross channel marketing, marketing database, data licensing, local search optimization, data processing, risk management, application programming interface (API) solutions,
    View Document
  • Chardan Capital Markets, LLC - Pharmaceuticals & Healthcare - Advisory Profile
    Chardan Capital Markets, LLC - Pharmaceuticals & Healthcare - Advisory Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    Chardan Capital Markets, LLC is engaged in providing financial services and investment opportunities in both Asian and American companies and institutions. The company offers services for IPO's, Private Investments in Public Equity (PIPEs), Specified Purpose Acquisition Companies (SPACs), Merger and Acquisition Advisory Services, Debt Financing, Private Equity Financing, Venture Capital Funding, Equities and Options Trading and Non Deal Road Shows. GlobalData’s Chardan Capital Markets, LLC - Pharmaceuticals & Healthcare - Advisory Profile provides an overview of the deals advised by Chardan Capital Markets, LLC in the Pharmaceuticals and Healthcare market. The report is an essential source of information for Pharmaceuticals and Healthcare companies, which require the services of financial/legal advisors in their area/region for raising capital or acquiring a company. The report summarizes Chardan Capital Markets, LLC's deals for the past five years segregated into year, deal type, segment and geography. Scope - Provides essential information on the financial deals in which the firm provided financial/legal advisory services. The deals include mergers and acquisitions, asset financing, asset transactions, private equity / venture capital deals, equity offerings, debt offerings, partnerships, and licensing agreements - Outlines key advisor information for business intelligence needs such as name, business overview, location and contact information - Analyzes the advisor’s deals by year, deal type, segment and geography - Provides detailed information on deal particulars, including information about other advisors involved in the deal - Includes information on the role played by the advisor in specific deals, and the extent of fees/commission charged by the advisor in a particular transaction, if disclosed - Consists of Deals Advised by Year chart and table displaying information on the number of deals and value reported by the advisor by year, for
    View Document
  • Mallesons Stephen Jaques - Power Energy - Advisory Profile
    Mallesons Stephen Jaques - Power Energy - Advisory Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    Mallesons Stephen Jaques (Mallesons) is a legal and advisory services firm providing litigation, dispute resolution, arbitration and mediation services for commercial and construction areas. Mallesons also provides tax advisory services. The company provides services for media and entertainment, energy and resources, telecommunications, healthcare and corporate industries. The company operates in Australia, China, Hong Kong and the U.K. Mallesons is headquartered at Sydney, Australia. In 2009, the company was awarded Best Large Professional Services Firm and Best Large Law Firm awards. GlobalData’s Mallesons Stephen Jaques - Power Energy - Advisory Profile provides an overview of the deals advised by Mallesons Stephen Jaques in the Power market. The report is an essential source of information for Power companies, which require the services of financial/legal advisors in their area/region for raising capital or acquiring a company. The report summarizes Mallesons Stephen Jaques's deals for the past five years segregated into year, deal type, segment and geography. Scope - Provides essential information on the financial deals in which the firm provided financial/legal advisory services. The deals include mergers and acquisitions, asset financing, asset transactions, private equity / venture capital deals, equity offerings, debt offerings, partnerships, and licensing agreements - Outlines key advisor information for business intelligence needs such as name, business overview, location and contact information - Analyzes the advisor’s deals by year, deal type, segment and geography - Provides detailed information on deal particulars, including information about other advisors involved in the deal - Includes information on the role played by the advisor in specific deals, and the extent of fees/commission charged by the advisor in a particular transaction, if disclosed - Consists of Deals Advised by Year chart and table displaying information on t
    View Document
  • Poyner Spruill LLP - Power Energy - Advisory Profile
    Poyner Spruill LLP - Power Energy - Advisory Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    Poyner Spruill LLP is a law firm , the firm provides its excellence in diverse practice areas as banking, credit & financial Services, bankruptcy & creditors' rights, construction law, corporate law, employment law, estates, trusts & exempt organizations, general litigation, government, legislative, and regulatory. The firm was formed by the merger of two law firms Poyner firm and Spruill & Spruill firm. The firm is the only North Carolina law firm member of the State Capital Group also a member of the USLAW NETWORK, GlobalData’s Poyner Spruill LLP - Power Energy - Advisory Profile provides an overview of the deals advised by Poyner Spruill LLP in the Power market. The report is an essential source of information for Power companies, which require the services of financial/legal advisors in their area/region for raising capital or acquiring a company. The report summarizes Poyner Spruill LLP's deals for the past five years segregated into year, deal type, segment and geography. Scope - Provides essential information on the financial deals in which the firm provided financial/legal advisory services. The deals include mergers and acquisitions, asset financing, asset transactions, private equity / venture capital deals, equity offerings, debt offerings, partnerships, and licensing agreements - Outlines key advisor information for business intelligence needs such as name, business overview, location and contact information - Analyzes the advisor’s deals by year, deal type, segment and geography - Provides detailed information on deal particulars, including information about other advisors involved in the deal - Includes information on the role played by the advisor in specific deals, and the extent of fees/commission charged by the advisor in a particular transaction, if disclosed - Consists of Deals Advised by Year chart and table displaying information on the number of deals and value reported by the advisor by year, for a five year period - Inc
    View Document
  • Hawkins Delafield & Wood LLP - Power Energy - Advisory Profile
    Hawkins Delafield & Wood LLP - Power Energy - Advisory Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    Hawkins Delafield & Wood provides services in legal advise with focus on public finance and projects. The firm's areas of practice include arbitrage rebate compliance, banking, economic and industrial development finance, securities law disclosure, higher education finance, real estate, project finance, and tax. The company is headquartered at New York and has offices at Connecticut, Los Angeles, New Jersey, Sacramento, San Francisco, Washington. GlobalData’s Hawkins Delafield & Wood LLP - Power Energy - Advisory Profile provides an overview of the deals advised by Hawkins Delafield & Wood LLP in the Power market. The report is an essential source of information for Power companies, which require the services of financial/legal advisors in their area/region for raising capital or acquiring a company. The report summarizes Hawkins Delafield & Wood LLP's deals for the past five years segregated into year, deal type, segment and geography. Scope - Provides essential information on the financial deals in which the firm provided financial/legal advisory services. The deals include mergers and acquisitions, asset financing, asset transactions, private equity / venture capital deals, equity offerings, debt offerings, partnerships, and licensing agreements - Outlines key advisor information for business intelligence needs such as name, business overview, location and contact information - Analyzes the advisor’s deals by year, deal type, segment and geography - Provides detailed information on deal particulars, including information about other advisors involved in the deal - Includes information on the role played by the advisor in specific deals, and the extent of fees/commission charged by the advisor in a particular transaction, if disclosed - Consists of Deals Advised by Year chart and table displaying information on the number of deals and value reported by the advisor by year, for a five year period - Incorporates information on the major recent
    View Document
  • Renaissance Securities (Cyprus) Limited - Power Energy - Advisory Profile
    Renaissance Securities (Cyprus) Limited - Power Energy - Advisory Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    Renaissance Securities (Cyprus) Limited is an investment bank. GlobalData’s Renaissance Securities (Cyprus) Limited - Power Energy - Advisory Profile provides an overview of the deals advised by Renaissance Securities (Cyprus) Limited in the Power market. The report is an essential source of information for Power companies, which require the services of financial/legal advisors in their area/region for raising capital or acquiring a company. The report summarizes Renaissance Securities (Cyprus) Limited's deals for the past five years segregated into year, deal type, segment and geography. Scope - Provides essential information on the financial deals in which the firm provided financial/legal advisory services. The deals include mergers and acquisitions, asset financing, asset transactions, private equity / venture capital deals, equity offerings, debt offerings, partnerships, and licensing agreements - Outlines key advisor information for business intelligence needs such as name, business overview, location and contact information - Analyzes the advisor’s deals by year, deal type, segment and geography - Provides detailed information on deal particulars, including information about other advisors involved in the deal - Includes information on the role played by the advisor in specific deals, and the extent of fees/commission charged by the advisor in a particular transaction, if disclosed - Consists of Deals Advised by Year chart and table displaying information on the number of deals and value reported by the advisor by year, for a five year period - Incorporates information on the major recent financial deals of the advisor. Each such deal carries a summary, deal type, deal rationale, deal financials and target company’s key financial metrics and ratios (financials are available for major public companies). Reasons to Buy - Receive detailed information and evaluate the profile of a particular advisor in the market before considering
    View Document
  • Cenkos Securities plc (CNKS) - Power Energy - Advisory Profile
    Cenkos Securities plc (CNKS) - Power Energy - Advisory Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    Cenkos Securities is an institutional securities firm on UK small and mid-cap companies. Its principal activities are corporate finance, corporate broking, institutional stock broking, investment funds, institutional sales and market making. GlobalData’s Cenkos Securities plc (CNKS) - Power Energy - Advisory Profile provides an overview of the deals advised by Cenkos Securities plc in the Power market. The report is an essential source of information for Power companies, which require the services of financial/legal advisors in their area/region for raising capital or acquiring a company. The report summarizes Cenkos Securities plc's deals for the past five years segregated into year, deal type, segment and geography. Scope - Provides essential information on the financial deals in which the firm provided financial/legal advisory services. The deals include mergers and acquisitions, asset financing, asset transactions, private equity / venture capital deals, equity offerings, debt offerings, partnerships, and licensing agreements - Outlines key advisor information for business intelligence needs such as name, business overview, location and contact information - Analyzes the advisor’s deals by year, deal type, segment and geography - Provides detailed information on deal particulars, including information about other advisors involved in the deal - Includes information on the role played by the advisor in specific deals, and the extent of fees/commission charged by the advisor in a particular transaction, if disclosed - Consists of Deals Advised by Year chart and table displaying information on the number of deals and value reported by the advisor by year, for a five year period - Incorporates information on the major recent financial deals of the advisor. Each such deal carries a summary, deal type, deal rationale, deal financials and target company’s key financial metrics and ratios (financials are available for major public companies). Re
    View Document
  • DSP Merrill Lynch Limited - Power Energy - Advisory Profile
    DSP Merrill Lynch Limited - Power Energy - Advisory Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    DSP Merrill Lynch Limited (DSPML) is a financial service provider in India. DSPML is the underwriter and broker for debt and equity securities and advisor to corporations and institutions. The company is also engaged in the debt and equity markets and is also a primary dealer of Government Securities. GlobalData’s DSP Merrill Lynch Limited - Power Energy - Advisory Profile provides an overview of the deals advised by DSP Merrill Lynch Limited in the Power market. The report is an essential source of information for Power companies, which require the services of financial/legal advisors in their area/region for raising capital or acquiring a company. The report summarizes DSP Merrill Lynch Limited's deals for the past five years segregated into year, deal type, segment and geography. Scope - Provides essential information on the financial deals in which the firm provided financial/legal advisory services. The deals include mergers and acquisitions, asset financing, asset transactions, private equity / venture capital deals, equity offerings, debt offerings, partnerships, and licensing agreements - Outlines key advisor information for business intelligence needs such as name, business overview, location and contact information - Analyzes the advisor’s deals by year, deal type, segment and geography - Provides detailed information on deal particulars, including information about other advisors involved in the deal - Includes information on the role played by the advisor in specific deals, and the extent of fees/commission charged by the advisor in a particular transaction, if disclosed - Consists of Deals Advised by Year chart and table displaying information on the number of deals and value reported by the advisor by year, for a five year period - Incorporates information on the major recent financial deals of the advisor. Each such deal carries a summary, deal type, deal rationale, deal financials and target company’s key financial metrics and
    View Document
  • Derma Sciences, Inc. (DSCI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
    Derma Sciences, Inc. (DSCI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    Derma Sciences, Inc. (Derma Sciences) is a medical technology company, which focuses on wound care. It is a fully integrated manufacturer, supplier and marketer of wound care and skin care products. Its product portfolio consists of novel patented dressings, barrier dressings, proprietary antimicrobial dressing, proprietary line of dressings, patented advanced dressing system, on-adherent impregnated dressings, gauze sponges and bandages, retention devices, paste bandages and other compression devices. Derma Sciences also distributes specialized and general purpose skin care products including antibacterial cleansing foams and sprays, body oils, shampoos and body washes, barrier creams and ointments, home healthcare agencies, bath additives, hand sanitizers and moisturizers. It has manufacturing facilities in Toronto, Canada; and Nantong, China. Derma Sciences is headquartered in New Jersey, the US. Derma Sciences focuses on the expansion of its product portfolio by building a strong operating base, besides gaining expertise through agreements, collaborations and acquisitions. This intent is reflected in its recent collaborations with New Cast Industries Co. Ltd. and Quick-Med Technologies, Inc. Derma Sciences, Inc. (DSCI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial de
    View Document
  • eResearchTechnology, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
    eResearchTechnology, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    eResearchTechnology, Inc. (ERT) is a technology-driven provider of health outcomes research services to biopharmaceutical sponsors and contract research organizations (CROs) and helps to achieve their drug development and healthcare objectives. ERT uses its technology, processes and scientific expertise to collect, analyze and report the clinical data to support the determination of health outcomes critical for the approval, labeling and reimbursement of pharmaceutical products. The company provides clinical outcome assessment solutions, respiratory efficacy services, and centralized cardiac safety. The company operates in the US, the UK, Germany and Japan. ERT is headquartered in Philadelphia, Pennsylvania, the US. eResearchTechnology, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and ta
    View Document
  • Farmstandart OAO (PHST) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
    Farmstandart OAO (PHST) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    Farmstandart OAO (Pharmstandard) is a leading Russia-based pharmaceutical company that develops, manufactures and distributes pharmaceutical products and devices. The company has a wide pharmaceutical product portfolio consisting of more than 250 products, over-the-counter drugs (OTC) and prescription drugs, covering a large number of therapeutic areas. Its pharmaceutical product portfolio consists of analgesics, cough and cold, vitamins, anti-viral, and antifungal therapeutic drugs. Pharmstandard provides generic pharmaceutical in various forms such as tablets, soluble tablets, pills, powder, gelatin capsules, sachets, ampoules, ointments, sprays, syrups, injections, and solutions. The company also provides medical equipment and disposables. During 2004-2011, the company developed more than 60 pharmaceutical products in collaboration with leading scientific centers in Russia. Pharmstandard is headquartered in Dolgoprudny, Moscow Oblast, Russian Federation. Farmstandart OAO (PHST) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, fo
    View Document
  • Genovis AB (GENO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
    Genovis AB (GENO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    Genovis AB (Genovis) is a biotechnology company. It undertakes the development and commercialization of innovative technologies for cellular research. Its product portfolio includes antibody fragmentation, antibody deglycosylation and magnetic nanoparticles. In antibody fragmentation segment the company provides, FabRICATOR, a specific proteolytic enzyme which cleaves all human, rabbit, monkey and sheep IgG subclasses. In antibody deglycosylation segment the company provides, IgGZER, a endoglucosidase with a specificity for IgG which cleaves the chitobiose core on IgG. In magnetic nanoparticles segment, the company provides, FeOdots - PEG coated magnetic nanoparticles, FeOlabel - lipid coated magnetic nanoparticles and Imaging services. It undertakes several research and development projects which focuses on design, characterization and production of nanostructures as contrast agents in medical imaging. It operates in US, Europe and Asia and has signed agreements with distributors in over 10 countries on three continents. The company is headquartered in Lund, Sweden. Genovis AB (GENO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and t
    View Document
  • OctoPlus N.V. (OCTO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
    OctoPlus N.V. (OCTO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    OctoPlus N.V. (OctoPlus) is one of the leading specialty pharmaceutical companies focused on the development and manufacture of improved injectable pharmaceuticals. The company is a subsidiary of Dr. Reddy’s Laboratories Ltd. The company develops and delivers pharmaceutical products which include locteron and OP-145. It provides pharmaceutical development services, controlled release drug delivery technologies and cGMP manufacturing of final product. The company’s key drugs include OctoDEX, PolyActive, SynBiosys and other vaccines. The company also offers contract development services such as formulation development, clinical manufacturing and fill and finish services. Moreover, OctoPlus offers special formulation and manufacturing services in the areas of protein and peptide formulations, freeze drying, liposomes, microspheres, solubilisation and emulsions. The company partners with Biolex Therapeutics and Leiden University Medical Centre. Octoplus is headquartered in Leiden, the Netherlands. OctoPlus N.V. (OCTO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value r
    View Document
  • MDxHealth SA (MDXH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
    MDxHealth SA (MDXH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    MdxHealth SA (MdxHealth), formerly OncoMethylome Sciences SA, is a molecular diagnostics company. The company develops and commercializes advanced molecular diagnostic tests for early cancer detection and personalized treatment decisions. It focuses mainly on three different types of cancers, namely, prostate cancer, colorectal cancer and lung cancer. The company's tests are based on its proprietary MSP methylation technology that assists physicians in the diagnosis of cancer. It also provides indications of cancer recurrence and prediction of response to a specific therapy. The company's product line includes molecular diagnostics, clinical diagnostics, and pharmaco diagnostics. It also offers innovative biomarker development services for many pharmaceutical companies. Geographically, the company has operations throughout Belgium and the US. MdxHealth is headquartered in Liege, Belgium. The major business strategy of the company envisages the provision of high value MDx products for use in the diagnosis and prognosis of cancers. It aims mainly to develop and commercialize cancer diagnostic products for personalized cancer treatment with focus on prostate, colon, brain and lung cancers. The company also plans to launch its first assay, Prostate ConfirmMDx, in fiscal year 2012. MDxHealth SA (MDXH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary resea
    View Document
  • Cytomedix, Inc. (CMXI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
    Cytomedix, Inc. (CMXI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    $250.00

    $250.00

    From:GlobalData

    Document Overview:
    Cytomedix, Inc. (Cytomedix) is an integrated regenerative medicine company that develops and commercializes innovative platelet and adult stem cell separation products that boosts the body's natural healing processes. Cytomedix’s advanced autologous technologies provide clinicians a new treatment paradigm for wound and tissue repair. The company’s commercial products include AutoloGel! System for wound care and the Angel Whole Blood Separation System. Also, Cytomedix is developing novel regenerative therapies using its proprietary ALDH Bright Cell technology to isolate an exclusive, biologically active population of a patient’s own stem cells. A Phase II trial evaluating the use of ALDHbr for the treatment of ischemic stroke is ongoing. Cytomedix’s patient-derived PRP systems are marketed in the US and distributed internationally. Cytomedix is headquartered in Gaithersburg, Maryland, the US. Cytomedix intends to expand its commitment to regenerative medicine. In this regard, the company acquired Aldagen, Inc. a privately held cell therapy company located in Durham, the US. Cytomedix, Inc. (CMXI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year
    View Document
Per Page: 152550